目录&服务
Inquiry and ordering
Yeast Hybridization Technology Service
After years of development, Tek Biotech has accumulated rich experience in immunology research and detection, and has rich experience in yeast library construction. Based on this, it provides high-quality yeast hybridization technology services to global customers, including yeast cDNA library construction technology services, yeast single hybridization technology services and yeast two-hybridization technology services.
█ Types of Yeast Hybridization Technology Services
TekBiotech has established a yeast hybridization verification system with the help of a mature yeast surface display technology platform. The principle is basically similar to that of antibody yeast surface display technology. Yeast hybridization technology can be divided into yeast single hybridization, yeast two-hybridization and yeast three-hybridization according to the type of detection. TekBiotech provides customers with yeast single hybridization and yeast two-hybridization technology services.
-- Yeast cDNA Library Construction Service
There are two conventional methods for constructing cDNA libraries: SMART technology and Gateway technology. Tianjin TekBiotech is good at using the SMART method combined with homologous recombination (homologous method of Gateway method) to construct cDNA display libraries. As shown in Figure 1, the SMART method synthesizes cDNA library:
Figure 1 Schematic diagram of SMART method for synthesizing cDNA library
For more information on yeast cDNA library construction technology, please refer to yeast cDNA expression library construction service
-- Yeast One-hybrid Technology Service (Y1H)
The yeast one-hybrid system belongs to the intranuclear interaction verification system, which is a gene reporting system built with the help of the biphasic functional characteristics of some cell transcription activators. In specific experimental operations, the transcription activator GAL4 is often used as a bridge to connect the upstream and downstream signal transduction. The basic principle is that the transcription factor GAL4 can regulate the expression of yeast galactosidase gene. When yeast expresses galactosidase, galactosidase catalyzes X-gal to produce blue colonies on the plate containing X-gal.
As shown in Figure 2, the transcription factor GAL4 contains two domains that can independently play a functional role: the transcription activation domain (AD) and the DNA binding domain (BD). The library containing various cDNA sequences was cloned into an expression vector with GAL4-AD to form vector 1; the cis-acting element was cloned into a vector with GAL4-BD to form vector 2. Then vector 1 and vector 2 are transformed into the same yeast cell for co-expression: if the fusion protein expressed by cDNA-GAL4-AD in vector 1 can bind to the cis-acting element in vector 2, the AD of GAL4 in vector 1 and the BD in vector 2 will combine to form a complete transcription factor GAL4, and GAL4 will bind to the upstream of the galactosidase gene, prompting the expression of the galactosidase gene to produce enzyme catalysis (i.e., reporter gene).
Figure 2 Principle of yeast one-hybrid system
For more information about yeast one-hybrid technology, please refer to yeast one-hybrid technology service
-- Yeast two-hybrid system (Y2H)
Similar to yeast one-hybrid technology, yeast two-hybrid technology uses the transcription activator to have two different domains: DNA binding domain (DNA-BD) and transcription activation domain (activation domain). The above two structures can function independently without affecting each other, but only when they are close enough in space can they exercise the activity of complete transcription activators, so that the downstream genes regulated by them can be transcribed. In the yeast two-hybrid system, the DNA-BD domain and the transcription factor AD domain are fused with X (bait protein) and Y (prey protein) to form fusion proteins. The DNA-BD domain-X fusion protein can recognize and bind to the upstream activator sequence (UAS: Upstream Activation Sequence) of the reporter gene. If the DNA-BD domain-X fusion protein interacts with the prey protein Y, this will make the DNA-AD domain and the BD domain approach each other and recombine to form a complete protein with the function of activating the reporter gene, and finally let the reporter gene express, as shown in Figure 3:
Figure 3 Principle of yeast two-hybrid system
Tianjin TekBiotech provides customers with two forms of yeast two-hybrid technology services: yeast two-hybrid technology (nuclear system) service and yeast two-hybrid technology (membrane system) service to meet the different project needs of customers.
(1)Yeast two-hybrid technology (nuclear system) service
Figure 4 Schematic diagram of yeast two-hybrid technology (nuclear system)
As shown in Figure 4, yeast two-hybrid technology (nuclear system) is similar to yeast one-hybrid technology, and uses the transcription activator GAL4 for library construction and screening. The library containing various cDNA sequences is cloned into an expression vector with GAL4-AD to form vector 1; the cis-acting element is cloned into a vector with GAL4-BD to form vector 2. Then vector 1 and vector 2 are transformed into the same yeast cell for co-expression: if the fusion protein expressed by cDNA-GAL4-AD in vector 1 can bind to the cis-acting element in vector 2, the AD of GAL4 in vector 1 and the BD in vector 2 will combine to form a complete transcription factor GAL4, and GAL4 will bind to the upstream of the galactosidase gene, prompting the expression of the galactosidase gene to produce enzyme activity catalysis (i.e., reporter gene).
For more information about yeast two-hybrid technology (nuclear system), please refer to yeast two-hybrid technology (nuclear system) service.
(2)Yeast Two-hybrid Technology (Membrane System) Service
Yeast two-hybrid technology (membrane system) is used to verify the interaction between membrane proteins and cytoplasmic proteins. The membrane protein interaction yeast two-hybrid system is based on the split-ubiquitin mediated separation-merge-cleavage system. The ubiquitin protein is divided into two domains: the N-terminal domain (called: Nub domain) and the C-terminal domain (called: Cub domain). These two domains can form a complete ubiquitin protein when they are close to each other inside the same cell. The ubiquitin protein can be recognized by ubiquitin-specific proteases (UBP, ubiquitin binding proteins; this enzyme recognizes the complete ubiquitin protein). The basic principle is shown in Figure 5:
Figure 5 Schematic diagram of membrane protein interaction yeast two-hybrid system
For more information about yeast two-hybrid technology (membrane system), please refer to yeast two-hybrid technology (membrane system) service
█ Advantages of Yeast Surface Display Technology Platform Service
Direct service from technical experts to meet different testing needs | Reliable results, cost-effective | High testing service efficiency, real-time process monitoring | High sensitivity of testing instruments, low sample consumption | Short experimental cycle, saving waiting time | Provide one-stop service: from library construction to positive clone screening, improve efficiency, avoid errors, and save costs |
The application of yeast hybrid technology in enzyme screening can effectively help optimize the activity, stability and specificity of enzymes. By introducing a library containing enzyme genes into yeast cells and performing high-throughput screening, enzymes with high affinity and activity for specific substrates can be screened. The advantage of this technology lies in its efficient gene expression ability and fast screening speed, making the enzyme optimization process more efficient. By combining flow sorting technology, enzymes with ideal performance can be selected from a large number of enzyme mutants, which are widely used in biocatalysis, environmental protection, and food industry.
Library construction of yeast hybrid technology usually includes several key steps. First, select the target gene or antibody gene, design appropriate primers, and obtain the target gene by PCR amplification. Then, clone the gene into a suitable yeast expression vector, usually using a yeast expression system such as the pYES series vector. Next, transform the constructed vector into yeast cells and obtain stable transformants through screening. Finally, in order to ensure the diversity of the library, it is necessary to amplify and optimize it by appropriate methods to ensure that the library contains enough unique genes for subsequent screening and analysis.
Yeast hybrid technology has the advantages of high efficiency and high throughput in antibody screening. First, the library containing antibody genes is introduced into yeast cells through transfection technology to express monoclonal antibodies displayed on the yeast surface. Then, a specific antigen is used for screening, and only antibodies that specifically bind to the antigen can be stably displayed on yeast cells. Through flow sorting technology, antibodies that bind to the target antigen can be screened out from a large number of unrelated antibodies. The whole process is both efficient and flexible, and is suitable for constructing and screening large-scale antibody libraries. The screened antibodies can be further used in applications such as disease diagnosis, targeted therapy and vaccine development.
Yeast hybrid technology is a gene expression and screening method based on yeast cells, which is mainly used to study protein-protein interactions, antibody screening, enzyme function research, and peptide and antibody optimization. This technology introduces two or more genes (such as genes encoding different proteins) into yeast cells, and uses the yeast's "hybridization" mechanism to allow genes or proteins from different sources to interact with each other. This technology can achieve efficient expression and screening in yeast cells, and has the advantages of high throughput and high efficiency. Yeast hybrid technology is widely used in drug development, antibody screening, enzyme optimization and other fields.
In antibody screening and optimization, yeast hybrid technology can help optimize antibody affinity. The affinity of antibodies to targets can be effectively improved by performing site-directed mutagenesis, affinity maturation and multiple rounds of screening on antibody genes. In yeast hybridization, antibodies are screened by their ability to bind to antigens, so repeated affinity screening can help discover antibodies with stronger binding. In addition, by optimizing expression conditions and controlling selection pressure, antibodies can also show higher stability and specificity in vitro. This makes yeast hybrid technology have important application value in antibody affinity optimization and antibody drug development.
To experience the reliable service of Tekbiotech please subscribe:
Antibody Discovery
Antibody Production
Antibody Modification
Contact
WeChat Official Account
Technical Support
©2025Tekbiotech (Tianjin) Co., Ltd津ICP备2021009144号-1津公网安备12011402001524号